Showing results (61-70 of 106) with videos related to
Sort By:
Pageof 11
JHEP Reports : Innovation in Hepatology|October 10, 2025
Cystic fibrosis liver disease progression in the era of elexacaftor-tezacaftor-ivacaftorCharlotte Mouliade, Lucia Parlati, Stylianos Tzedakis, et al.The Journal of Biological Chemistry|July 20, 2006
Signal peptide peptidase-catalyzed cleavage of hepatitis C virus core protein is dispensable for virus budding but destabilizes the viral capsidChristelle Vauloup-Fellous, Véronique Pène, Julie Garaud-Aunis, et al.Plos One|July 6, 2018
Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patientsIssifou Yaya, Perrine Roux, Fabienne Marcellin, et al.AIDS and Behavior|April 27, 2021
HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)Tangui Barré, Patrick Mercié, Fabienne Marcellin, et al.Journal of Hepatology|June 3, 2014
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG studyPatrick Miailhes, Marianne Maynard-Muet, Fanny Lebossé, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2018
Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected PatientsIsabelle Poizot-Martin, Eric Rosenthal, Camille Gilbert, et al.European Journal of Gastroenterology & Hepatology|May 17, 2019
Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort)Marie Costa, Teresa Rojas Rojas, Denis Lacoste, et al.Nutrients|August 23, 2020
Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)Saskia Antwerpes, Camelia Protopopescu, Philippe Morlat, et al.Nutrients|June 3, 2018
Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort)Issifou Yaya, Fabienne Marcellin, Marie Costa, et al.Addiction (Abingdon, England)|April 22, 2017
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohortRod Knight, Perrine Roux, Antoine Vilotitch, et al.Pageof 11